Hidden liver risk in type 1 diabetes: a new study investigates
NCT ID NCT07750210
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study looks at how common fatty liver disease (MASLD) is in adults with type 1 diabetes. Researchers will check 250 adults with type 1 diabetes for signs of liver fat and scarring, using non-invasive tests. The goal is to understand if type 1 diabetes raises the risk of liver problems and to find better ways to detect them early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could lead to better ways to detect and monitor fatty liver disease in people with type 1 diabetes, potentially preventing serious liver damage.
- What could go wrong
- This is an observational study, so it won't test a treatment. It may not capture all cases, and the findings might not apply to everyone with type 1 diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University Hospital
Sohag, Sohag Governorate, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Smart insulin pump aims to end dangerous nighttime blood sugar swings
- Could diabetes be silently damaging your hearing?
- Heart scans could flag Who's at risk after liver shunt
- Could a common b vitamin tame fatty liver?
- Can a wearable sensor outsmart diabetic ketoacidosis?